FAST-IRM for HCC suRveillance in pAtients With High risK of Liver Cancer.

Abroad (travel likely)Recruiting

Conditions

Hepatocellular Carcinoma · Liver Cancer · Cirrhosis · Chronic Liver Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Assistance Publique Hôpitaux de Paris - Hôpital Avicenne, Bondy, France

Study leads

Pierre NAHON, MD, PhD
Study Director
Assistance Publique Hôpitaux de Paris (AP-HP)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Biannual Screening for HCC Offered to Patients With Cirrhosis. Introducing Surveillance for Hepatocellular Carcinoma (HCC) in the Central Denmark Region Using Ultrasound and Alpha-Fetoprotein to Reduce HCC-Related Mortality in Patients With Compensated Non-Viral Cirrhosis

Hepatocellular Carcinoma (HCC) · Cirrhosis

Abroad (travel likely)Recruiting

Aarhus, Denmark · Herning, Denmark

To Evaluate the Safety, Tolerability, and Preliminary Efficacy of XH001 Injection as Adjuvant Therapy in Patients With High-risk Recurrent Solid Tumors

Biliary Cancer (Cholangiocarcinoma, Gall Bladder Cancer) · Pancreatic Ductal Adenocarcinoma (PDAC) · Hepatocellular Carcinoma (HCC)

Abroad (travel likely)RecruitingPHASE1

Beijing, China · Beijing, China

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Colorectal Carcinoma · Endometrial Carcinoma · Melanoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Birmingham, United States · Los Angeles, United States

A Prospective, Randomized Study of TACE Combined With Sintilimab, Bevacizumab, and Ipilimumab N01 Treating Advanced HCC

Hepatocellular Carcinoma (HCC)

Abroad (travel likely)RecruitingPHASE2

Hangzhou, China